Hydralazine Therapy

Hydralazine Therapy is a pharmacological intervention within the class of vasodilator therapies that specifically utilizes hydralazine, a direct-acting arterial smooth muscle relaxant, to reduce systemic vascular resistance and lower blood pressure primarily through selective dilation of arterioles.

979

Publications

49.9K

Citations

3.3K

Authors

880

Institutions

Publications per year

2017–2026

54

Variants

Hydralazine Treatment

Authors

3.3K

  1. JN
    Jay N. Cohn

    University of Minnesota Medical Center, United States

    19 publications · 5.6K citations

    18

    h-index

  2. JL
    J. L. McNay

    Emory University, United States

    13 publications · 441 citations

    12

    h-index

  3. AM
    Alexander M. M. Shepherd

    The University of Texas at San Antonio Health Science Center, United States

    11 publications · 313 citations

    11

    h-index

  4. KC
    Kanu Chatterjee

    University of California, San Francisco, United States

    10 publications · 1.2K citations

    10

    h-index

  5. AD
    Alfonso Dueñas‐González

    Instituto Nacional de Cancerología, Mexico

    10 publications · 1K citations

    10

    h-index

1–5 of 3.3K

Venues

  1. Circulation

    56 publications · 4.1K citations

    37

    h-index

  2. PubMed

    Repository · 95 publications · 3.5K citations

    31

    h-index

  3. Hypertension

    46 publications · 2.9K citations

    29

    h-index

  4. 22

    h-index

  5. The American Journal of Cardiology

    23 publications · 1.1K citations

    18

    h-index

1–5